RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
Ponce Aix, S, Novello, S, Garon, EB, Nakagawa, K, Nadal, E, Moro-Sibilot, D, Alonso Garcia, M, Fabre, E, Frimodt-Moller, B, Zimmermann, AH, Visseren-Grul, CM, Reck, M
Published in Cancer treatment and research communications (2021)
Published in Cancer treatment and research communications (2021)
Get full text
Journal Article
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
VON DER MAASE, H, HANSEN, S. W, KERBRAT, P, ROVIRA, P. S, WERSALL, P, CLEALL, S. P, ROYCHOWDHURY, D. F, TOMLIN, I, VISSEREN-GRUL, C. M, CONTE, P. F, ROBERTS, J. T, DOGLIOTTI, L, OLIVER, T, MOORE, M. J, BODROGI, I, ALBERS, P, KNUTH, A, LIPPERT, C. M
Published in Journal of clinical oncology (17.09.2000)
Published in Journal of clinical oncology (17.09.2000)
Get full text
Journal Article
Phase II study of gemcitabine in ovarian cancer
Minckwitz, G. von, Bauknecht, T., Visseren-Grul, C. M., Neijt, J. P.
Published in Annals of oncology (01.07.1999)
Published in Annals of oncology (01.07.1999)
Get full text
Journal Article